Overview

Prospective Study to Determine the Effect of Subconjunctival Bevacizumab (AVASTIN) in Corneal Neovascularization

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
To determine the effect of subconjunctival Bevacizumab in corneal neovascularization
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Asociación para Evitar la Ceguera en México
Collaborators:
National Council of Science and Technology, Mexico
Universidad Nacional Autonoma de Mexico
Treatments:
Bevacizumab